D.E. Shaw & Co’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
+268,625
New +$1.42M ﹤0.01% 3563
2026
Q1
– Sell
-629,500
Closed -$3.68M – 4669
2025
Q4
$3.68M Buy
629,500
+172,625
+38% +$1.34M ﹤0.01% 2568
2025
Q3
$3.64M Sell
456,875
-14,554
-3% -$129K ﹤0.01% 2488
2025
Q2
$3.41M Sell
471,429
-388,428
-45% -$2.03M ﹤0.01% 2321
2025
Q1
$4.42M Sell
859,857
-1,594,000
-65% -$11.3M ﹤0.01% 1986
2024
Q4
$18.7M Buy
2,453,857
+1,224,000
+100% +$8.59M 0.01% 1076
2024
Q3
$8.04M Sell
1,229,857
-201,143
-14% -$1.67M 0.01% 1579
2024
Q2
$15.5M Buy
1,431,000
+170,429
+14% +$1.14M 0.01% 1053
2024
Q1
$7.07M Buy
1,260,571
+1,056,000
+516% +$7.33M 0.01% 1639
2023
Q4
$1.79M Sell
204,571
-128,000
-38% -$1.01M ﹤0.01% 2751
2023
Q3
$2.92M Buy
332,571
+148,857
+81% +$1.7M ﹤0.01% 2275
2023
Q2
$2.32M Buy
183,714
+146,714
+397% +$1.37M ﹤0.01% 2511
2023
Q1
$386K Sell
37,000
-130,286
-78% -$856K ﹤0.01% 3662
2022
Q4
$1.46M Hold
167,286
– – ﹤0.01% 3180
2022
Q3
$2.15M Buy
+167,286
New +$1.98M ﹤0.01% 2937

Other funds holding ENVX

D.E. Shaw & Co's ENVX Position: Q2 2026 in Review

D.E. Shaw & Co increased its Enovix (ENVX) stake by 7,568% in Q2 2026, buying an estimated $6.25M and bringing the position to 1,193,998 shares worth $5.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

D.E. Shaw & Co first reported a position in ENVX in Q1 2021 and has held it in 13 quarters since. The position peaked at $10.2M in Q3 2025. 302 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • D.E. Shaw & Co held 1,193,998 shares of Enovix worth $5.8M as of Q2 2026.
  • D.E. Shaw & Co bought 1,178,427 Enovix shares in Q2 2026, an estimated $6.25M.
  • Enovix made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2277 holding.
  • D.E. Shaw & Co first reported a position in Enovix in Q1 2021 and has held it in 13 quarters since.
  • D.E. Shaw & Co's Enovix position peaked at $10.2M in Q3 2025.
  • 302 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.